Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein

References

1. Akusjärvi G., Pettersson U. 1979; Sequence analysis of adenovirus DNA: complete nucleotide sequence of the spliced 5′ noncoding region of adenovirus 2 hexon messenger RNA. Cell 16:841–850
   [Google Scholar]
2. Amalfitano A., Begy C. R., Chamberlain J. S. 1996; Improved adenovirus packaging cell lines to support the growth of replication- defective gene-delivery vectors. Proceedings of the National Academy of Sciences, USA 93:3352–3356
   [Google Scholar]
3. Arnberg N., Mei Y.-F., Wadell G. 1997; Fiber genes of adenoviruses with tropism for the eye and the genital tract. Virology 227:239–244
   [Google Scholar]
4. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. 1997; Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323
   [Google Scholar]
5. Brough D. E., Lizonova A., Hsu C., Kulesa V. A., Kovesdi I. 1996; A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. Journal of Virology 70:6497–6501
   [Google Scholar]
6. Caravokyri C., Leppard K. N. 1995; Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5. Journal of Virology 69:6627–6633
   [Google Scholar]
7. Chee-Sheung C. C., Ginsberg H. S. 1982; Characterization of a temperature-sensitive fiber mutant of type 5 adenovirus and effect of the mutations on virion assembly. Journal of Virology 42:932–950
   [Google Scholar]
8. Chow L. T., Gelinas R. E., Broker T. R., Roberts R. J. 1997; An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA. Cell 12:1–8
   [Google Scholar]
9. Chroboczek J., Bieber F., Jacrot B. 1992; The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186:280–285
   [Google Scholar]
10. Chroboczek J., Ruigrok R. W. H., Cusack S. 1995; Adenovirus fiber. In The Molecular Repertoire of Adenoviruses pp. 164–200 Doerfler W., Bohm P. Edited by Berlin: Springer-Verlag;
    [Google Scholar]
11. Dai Y., Schwarz E. M., Gu D., Zhang W.-W., Sarvetnick N., Verma I. M. 1997; Cellular and humoral immune responses to adenoviral vectors containing factor IX gene : tolerization of factor IX and vector antigens allows for long-term expression. Proceedings of the National Academy of Sciences, USA 92:1401–1405
    [Google Scholar]
12. Dolph P. J., Racaniello V., Villamarin A., Palladino F., Schneider R. J. 1988; The adenovirus tripartite leader may eliminate the requirement for cap-binding protein complex during translation initiation. Journal of Virology 62:2059–2066
    [Google Scholar]
13. Engelhardt J. F., Ye X., Doranz B., Wilson J. M. 1994; Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proceedings of the National Academy of Sciences, USA 91:6196–6200
    [Google Scholar]
14. Fender P., Ruigrok R. W. H., Gout E., Buffet S., Chroboczek J. 1997; Adenovirus dodecahedron, a new vector for human gene transfer. Nature Biotechnology 15:52–56
    [Google Scholar]
15. Fisher K. J., Choi H., Burda J., Chen S.-J., Wilson J. M. 1996; Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217:11–22
    [Google Scholar]
16. Gall J., Kass-Eisler A., Leinwand L., Falck-Pedersen E. 1996; Adenovirus type 5 and 7 capsid chimera : fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. Journal of Virology 70:2116–2123
    [Google Scholar]
17. Gorziglia M. I., Kadan M. J., Yei S., Lim J., Lee G. M., Luthra R., Trapnell B. C. 1996; Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. Journal of Virology 70:4173–4178
    [Google Scholar]
18. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
19. Haecker S. E., Stedman H. H., Balice-Gordon R. J., Smith D. B. J., Greelish J. P., Mitchell M. A., Wells A., Sweeney H. L., Wilson J. M. 1996; In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Human Gene Therapy 7:1907–1914
    [Google Scholar]
20. Harlow E., Lane D. 1988 Antibodies Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
21. Henry L. J., Xia D., Wilke M. E., Deisenhofer J., Gerard R. D. 1994; Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli . Journal of Virology 68:5239–5246
    [Google Scholar]
22. Huang S., Kamata T., Takada Y., Ruggeri Z. M., Nemerow G. R. 1996; Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. Journal of Virology 70:4502–4508
    [Google Scholar]
23. Kochanek S., Clemens P. R., Mitani K., Chen H.-H., Chan S., Caskey C. T. 1997; A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proceedings of the National Academy of Sciences, USA 93:5731–5736
    [Google Scholar]
24. Kozak M. 1986; Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283–292
    [Google Scholar]
25. Kozarsky K. F., Wilson J. M. 1993; Gene therapy: adenovirus vectors. Current Opinion in Genetics and Development 3:499–503
    [Google Scholar]
26. Krasnykh V. N., Mikheeva G. V., Douglas J. T., Curiel D. T. 1996; Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. Journal of Virology 70:6839–6846
    [Google Scholar]
27. Krougliak V., Graham F. L. 1995; Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Human Gene Therapy 6:1575–1586
    [Google Scholar]
28. Kumar-Singh R., Chamberlain J. S. 1997; Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Human Molecular Genetics 5:913–921
    [Google Scholar]
29. Langer S. J., Schaack J. 1996; 293 cell lines that inducibly express high levels of adenovirus type 5 precursor terminal protein. Virology 221:172–179
    [Google Scholar]
30. Levine A. J., Ginsberg H. S. 1967; Mechanism by which fiber antigen inhibits multiplication of type 5 adenovirus. Journal of Virology 1:747–757
    [Google Scholar]
31. Michael S. I., Hong J. S., Curiel D. T., Engler J. A. 1995; Addition of a short peptide ligand to the adenovirus fiber protein. Gene Therapy 2:660–668
    [Google Scholar]
32. Mitani K., Graham F. L., Caskey C. T., Kochanek S. 1995; Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proceedings of the National Academy of Sciences, USA 92:3854–3858
    [Google Scholar]
33. Novelli A., Boulanger P. A. 1991; Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 185:365–376
    [Google Scholar]
34. Philipson L., Lonberg-Holm K., Petterson U. 1968; Virus-receptor interaction in an adenovirus system. Journal of Virology 2:1064–1075
    [Google Scholar]
35. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
36. Schaack J., Guo X., Yew-WaiHo W., Karlok M., Chen C., Ornelles D. 1995; Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines. Journal of Virology 69:4079–4085
    [Google Scholar]
37. Sheay W., Nelson S., Martinez I., Chu T.-H.T., Bhatia S., Dornburg R. 1993; Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eukaryotic vectors. BioTechniques 15:856–862
    [Google Scholar]
38. Stevenson S. C., Rollence M., White B., Weaver L., McClelland A. 1995; Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. Journal of Virology 69:2850–2857
    [Google Scholar]
39. Stevenson S. C., Rollence M., Marshall-Neff J., McClelland A. 1997; Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. Journal of Virology 71:4782–4790
    [Google Scholar]
40. Stratford-Perricaudet L. D., Makeh I., Perricaudet M., Briand P. 1992; Widespread long-term gene transfer to mouse skeletal muscles and heart. Journal of Clinical Investigation 90:626–630
    [Google Scholar]
41. Thiel J. F., Smith K. O. 1967; Fluorescent focus assay of viruses on cell monolayers in plastic Petri plates. Proceedings of the Society for Experimental Biology and Medicine 125:892–895
    [Google Scholar]
42. Tomko R. P., Xu R., Philipson L. 1997; HCAR and MAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proceedings of the National Academy of Sciences, USA 94:3352–3356
    [Google Scholar]
43. Wang Q., Jia X.-C., Finer M. H. 1995; A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Gene Therapy 2:775–783
    [Google Scholar]
44. Weinberg D. H., Ketner G. 1983; A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2. Proceedings of the National Academy of Sciences, USA 80:5383–5386
    [Google Scholar]
45. Wickham T. J., Mathias P., Cheresh D. A., Nemerow G. R. 1993; Integrins α_vβ₃ and α_vβ₅ promote adenovirus internalization but not virus attachment. Cell 73:309–319
    [Google Scholar]
46. Yang Y., Nunes F., Berencsi K., Furth E. E., Gönczöl E., Wilson J. M. 1994; Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proceedings of the National Academy of Sciences, USA 91:4407–4411
    [Google Scholar]
47. Yang Y., Su Q., Wilson J. M. 1996; Role of viral antigens in destructive cellular immune responses to adenovirus-transduced cells in mouse lungs. Journal of Virology 70:7209–7212
    [Google Scholar]
48. Yeh P., Dedieu J.-F., Orsini C., Vigne E., Denefle P., Perricaudet M. 1996; Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. Journal of Virology 70:559–565
    [Google Scholar]
49. Zhang Y., Feigenblum D., Schneider R. J. 1994; A late adenovirus factor induces eIF-4E dephosphorylation and inhibition of cell protein synthesis. Journal of Virology 68:7040–7050
    [Google Scholar]
50. Zhou H., O’Neal W., Morral N., Beaudet A. L. 1996; Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted. Journal of Virology 70:7030–7038
    [Google Scholar]